|
Volumn 128, Issue 41, 2006, Pages 13348-13349
|
Lipid encapsulation of arsenic trioxide attenuates cytotoxicity and allows for controlled anticancer drug release
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ARSENIC TRIOXIDE;
LIPID;
LIPOSOME;
NANOPARTICLE;
RITUXIMAB;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CONTROLLED DRUG RELEASE;
CONTROLLED STUDY;
CYTOTOXICITY;
DRUG FORMULATION;
ENCAPSULATION;
HUMAN;
HUMAN CELL;
LYMPHOMA CELL LINE;
PH;
PHASE TRANSITION;
TEMPERATURE SENSITIVITY;
ANTINEOPLASTIC AGENTS;
ARSENICALS;
CAPSULES;
CHEMISTRY, PHARMACEUTICAL;
DOXORUBICIN;
DRUG DELIVERY SYSTEMS;
HUMANS;
HYDROGEN-ION CONCENTRATION;
KINETICS;
LIPIDS;
LIPOSOMES;
LYMPHOCYTES;
MICROSCOPY, ELECTRON, TRANSMISSION;
OXIDES;
TEMPERATURE;
TUMOR CELLS, CULTURED;
|
EID: 33750051041
PISSN: 00027863
EISSN: None
Source Type: Journal
DOI: 10.1021/ja064864h Document Type: Article |
Times cited : (104)
|
References (14)
|